30

nanotimes

Companies

Facts

N

anometrics Incorporated (NASDAQ: NANO), a leading supplier of advanced process control

metrology systems used primarily in the manufactu- ring and packaging of semiconductors, solar photo- voltaics and high-brightness LEDs, announced that additional UniFire™ 7900 metrology systems have been delivered and qualified by an existing custo- mer, and are currently in production for high volume manufacturing process control of advanced wafer- level packaging processes. This multi-system follow- on installation is part of an ongoing program to deploy Nanometrics’ UniFire technology across mul- tiple manufacturing sites. The systems are being used to measure critical dimensions (CD), topography and overlay registration at the 32nm node for die prepa- ration applications.

http://www.nanometrics.com

n

anoMR Inc. received another $2.5 million in venture capital in January to conduct clinical tri-

als on a device to rapidly diagnose bacteria in blood. To date, nanoMR has received $8 million in funding and recently started its first clinical study. nanoMR has developed a proprietary detection technology based on miniaturized nuclear magnetic resonance.

New Mexico Business Weekly, April 23, 2010

http://www.nanomr.com

N

ano Retina has received a grant for just under three-quarters of one million dollars from the

Israel-U.S. Binational Industrial Research and Deve- lopment (BIRD) Foundation. The financing will be used to further develop the Bio-Retina, a “bionic retina” designed to return full sight to those blinded by retinal degenerative conditions. Bio-Retina is a tiny implant designed to replace the damaged retina in the eye. The implant‘s nano-sized components are

powered by a special pair of activation eyeglasses. Bio-Retina will be surgically implanted in a minimally invasive, 30-minute procedure, which requires only local anesthesia. Full sight is anticipated instantane- ously.

“50,000 people in the United States become blind annually. In addition, there are currently 3.6 million Americans aged 40 and older who are legally blind. Bio-Retina is designed to restore full sight to those blinded by degenerative conditions such as AMD, Diabetes Retinopathy or Retinitis Pigmentosa. By full sight we mean the patient will be able to watch TV and identify faces,” said

Ra’anan Gefen, managing director of Nano Retina: “We have a working ‘electrical’ prototype and have demonstrated proof of concept. We intend to use the generous funding from BIRD to miniaturize the system and develop a ‘nano’ prototype. All of the medical and technology industry experts with whom we have consulted agree that our product develop- ment expectations are attainable. We have laid the development foundation and now expect to begin clinical trials in 2012.”

http://www.nano-retina.com http://www.rainbowmedical.co.il http://www.zyvexlabs.com

N N

anosphere, Inc. (NASDAQ: NSPH) announced that it intends to offer shares of its common

stock in a public offering.

http://www.nanosphere.us

anoString Technologies, Inc., a privately held life sciences company marketing a comple- te solution for detecting and counting large sets of

10-04 :: April 2010